Home LiteratureArticle Details
PMID: 17639504 Published · ppublish English Journal Article

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

The Prostate ·Vol. 67 ·No. 13 ·2007-09-15 ·Pages 1432-8

van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA, Schalken JA

Abstract

To determine the value of loss of expression of E-cadherin and cadherin associated molecules as prognostic markers for prostate cancer patients in a long-term follow-up study. Sixty-five prostate cancer specimens, obtained from patients with different stages of prostate cancer who underwent a radical prostatectomy or TUR-P between 1987 and 1991, were used for immunohistochemical analysis of the expression pattern of E-cadherin, alpha-, beta-, gamma-catenin and p120(ctn). Clinical records of these patients were studied for follow-up data and the prognostic value of expression of these adhesion molecules was determined by Kaplan-Meier survival analyses and multivariable proportional hazard regression analysis. Normal staining patterns were found in 36 cases (55.4%) for E-cadherin, 37 cases (56.9%) for alpha-catenin, 40 cases (61.5%) for beta-catenin, 25 cases (38.5%) for gamma-catenin, and 40 cases (61.5%) for p120(ctn). Overall, a strong correlation was found between the expression of E-cadherin and other cadherin-associated molecules. The 5-year survival rates for each staining were as follows: E-cadherin (normal 79.2%, aberrant 26.8%), alpha-catenin (normal 79.2%, aberrant 26.8%), beta-catenin (normal 73.1%, aberrant 27.3%), gamma-catenin (normal 86.4%, aberrant 37.1%), and p120(ctn) (normal 72.8%, aberrant 30.0%). There was a significant difference in survival between normal and aberrant expression in each staining (log rank P < 0.0001). The proportional hazard regression model including tumor stage and Gleason score revealed alpha-catenin expression as the best prognostic marker for patients with prostate cancer. Our data revealed a strong correlation between E-cadherin expression and other cadherin-associated molecules. Among these markers, alpha-catenin seems the best prognostic marker for prostate cancer specific survival. Larger studies are needed to confirm this result.

MeSH Terms
Adult Aged Aged, 80 and over Biomarkers, Tumor/biosynthesis Cadherins/biosynthesis Catenins/biosynthesis Cell Adhesion Molecules/biosynthesis Disease-Free Survival Follow-Up Studies Humans Immunohistochemistry Kaplan-Meier Estimate Male Middle Aged Multivariate Analysis Phosphoproteins/biosynthesis Predictive Value of Tests Prostatic Neoplasms/metabolism,pathology,surgery
Chemicals
Biomarkers, Tumor Cadherins Catenins Cell Adhesion Molecules Phosphoproteins delta catenin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
van Oort I M
Department of Urology, Radboud University Nijmegen Medical Centre, HB Nijmegen, The Netherlands.
Tomita K
van Bokhoven A
Bussemakers M J G
Kiemeney L A
Karthaus H F M
Witjes J A
Schalken J A
Article Info
Journal
The Prostate
Abbr.
Prostate
ISSN
0270-4137
Published
2007-09-15
Pages
1432-8
Language
English
Region
United States
NLM ID
8101368
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com